NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Ann (ANN) was downgraded to neutral from buy at Janney Montgomery. $35 price target. Traffice is weakening, Janney said.
Cavium (CAVM) was upgraded to outperform from neutral at Wedbush. $42 price target. The company can deliver solid growht in 2014, Wedbush said.
Cisco (CSCO) was downgraded to underweight from netural at J.P. Morgan. $17 price target. The company will be hurt by emerging market weakness, said J.P. Morgan.
DHT Holdings (DHT) was upgraded to a hold rating by TheStreet Ratings.
E*Trade (ETFC) was upgraded to outperform from market perform by JMP Securities. $26 price target. Risks have diminished and the company is in the midst of a recovery, said JMP.
Juniper Networks (JNPR) was upgraded to a buy at TheStreet Ratings.
Lululemon (LULU) was downgraded to neutral from buy at Janney Montgomery. $49 price target. It may be too early to call a turn in the business, Janney said.
Mohawk (MHK) was upgraded to overweight from neutral by J.P. Morgan. $170 price target. The company has multiple potential catalysts, said J.P. Morgan.
Mallinckrodt (MNK) was downgraded to sell from neutral at UBS. $43 price target. This is a valuation call as business has seen shrinking margins and supply disruptions, said UBS.
Merck (MRK - Get Report) was upgraded to overweight from underweight by Morgan Stanley. $60 price target. The company is cutting costs and should see a positive oncology newsflow, said Morgan Stanley.
RetailMeNot (SALE) was upgraded to buy from neutral by Goldman Sachs. $40 price target. Mobile usage should improve traffic, Goldman said.
Xerox (XRX - Get Report) was downgraded to market perform from outperform at BMO Capital. $11.50 price target. This was a valuation call, said BMO.